A multicenter randomized controlled clinical trial using a new resorbable non‐cross‐linked collagen membrane for guided bone regeneration at dehisced single implant sites: interim results of a bone augmentation procedure

Abstract

OBJECTIVE To compare clinical performance of a new resorbable non-cross-linked collagen membrane, creos xenoprotect (CXP), with a reference membrane (BG) for guided bone regeneration at dehisced implant sites. MATERIALS AND METHODS This randomized controlled clinical trial enrolled patients with expected dehiscence defects following implant placement to… (More)
DOI: 10.1111/clr.12995

2 Figures and Tables

Topics

  • Presentations referencing similar topics